Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing

Stavudine remains a useful replacement option for treatment for HIV(+) children. WHO reduced the adult dose to 30 mg twice daily, which maintains efficacy and lowers mitochondrial toxicity. We explored intracellular stavudine triphosphate levels in children receiving a reduced dose of 0.5 to 0.75 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Innes, Steve, van der Laan, Louvina, Anderson, Peter L., Cotton, Mark, Denti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201115/
https://www.ncbi.nlm.nih.gov/pubmed/30104267
http://dx.doi.org/10.1128/AAC.00761-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201115/
https://www.ncbi.nlm.nih.gov/pubmed/30104267
http://dx.doi.org/10.1128/AAC.00761-18

Ejemplares similares